Skip to main content
SpringerLink
Log in

The Case for Bariatric Surgery in Patients with Class 1 Obesity

  • Bariatric Surgery (M. Kligman, Section Editor)
  • Published:
Current Surgery Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This mini-review reports the current research and arguments for extending the inclusion criteria to offer bariatric surgery in the treatment of class 1 obesity (body-mass index of 30–35 kg/m2) and obesity-related comorbidities.

Recent Findings

Recent studies have described the benefit of bariatric surgery in the treatment and resolution of obesity-related comorbidities in patients with class 1 obesity, notably, type 2 diabetes.

Summary

Bariatric surgery cremains the single most effective intervention to effectively reduce excess weight and ameliorate metabolic comorbidities. Patients with class 1 obesity have largely been excluded from bariatric surgery due to longstanding guidelines. As societal recommendations for bariatric surgery candidacy have recently broadened, this mini-review examines the most common currently offered bariatric procedures, guidelines and indications, procedure selection, outcomes of notable random control trials and observational studies, safety and cost considerations, as well as medical management and endobariatrics specifically in the context of treating patients with class 1 obesity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data Availability

Not applicable.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Clapp B, et al. American society for metabolic and bariatric surgery 2020 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis. 2022;18(9):1134–40.

    Article  PubMed  Google Scholar 

  2. Ward ZJ, et al. Projected US state-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440–50.

    Article  PubMed  Google Scholar 

  3. •• Aminian A, et al. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30–35 kg/m(2)). Surg Obes Relat Dis. 2018;14(8):1071–87. This paper represents the most up-to-date guidelines by the primary bariatric governing bodies, and is evidence-based.

  4. Uhe I, et al. Roux-en-Y gastric bypass, sleeve gastrectomy, or one-anastomosis gastric bypass? A systematic review and meta-analysis of randomized-controlled trials. Obesity (Silver Spring). 2022;30(3):614–27.

    Article  CAS  PubMed  Google Scholar 

  5. •• Sjostrom L, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52. This is a seminal study demonstrating survival benefit in patients who received bariatric surgery.

  6. Bhogal SK, et al. Inequity to the utilization of bariatric surgery: a systematic review and meta-analysis. Obes Surg. 2015;25(5):888–99.

    Article  PubMed  Google Scholar 

  7. Eisenberg, D, et al. 2022 American society for metabolic and bariatric surgery (ASMBS) and international federation for the surgery of obesity and metabolic disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18(12):1345–56.

    Article  PubMed  Google Scholar 

  8. Arterburn DE, et al. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–87.

    Article  PubMed  Google Scholar 

  9. Sharples AJ, Mahawar K. Systematic review and meta-analysis of randomised controlled trials comparing long-term outcomes of Roux-En-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2020;30(2):664–72.

    Article  PubMed  Google Scholar 

  10. Han Y, Yia J, Wang H, Cao L, Zhao Y. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: A systematic review and meta-analysis based on 18 studies. Int J Surg. 2020;76:101–10.

    Article  PubMed  Google Scholar 

  11. Santos MPD, et al. Safety and effectiveness of laparoscopic Y-en-Roux gastric bypass surgery in obese elderly patients. Acta Cir Bras. 2020;35(6):e202000606.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lynn W, et al. Laparoscopic Roux-en-Y gastric bypass is as safe as laparoscopic sleeve gastrectomy. Results of a comparative cohort study. Ann Med Surg (Lond). 2018;35:38–43.

    Article  CAS  PubMed  Google Scholar 

  13. Nguyen NT, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg. 2001;234(3):279–89 (discussion 289-91).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Banka G, et al. Laparoscopic vs open gastric bypass surgery: differences in patient demographics, safety, and outcomes. Arch Surg. 2012;147(6):550–6.

    Article  PubMed  Google Scholar 

  15. Fisher OM, et al. Barrett’s oesophagus and bariatric/metabolic surgery-IFSO 2020 position statement. Obes Surg. 2021;31(3):915–34.

    Article  PubMed  Google Scholar 

  16. Silveira FC, et al. The effect of laparoscopic sleeve gastrectomy on gastroesophageal reflux disease. Obes Surg. 2021;31(3):1139–46.

    Article  PubMed  Google Scholar 

  17. Leslie D, et al. Gastroesophageal reflux disease outcomes after vertical sleeve gastrectomy and gastric bypass. Ann Surg. 2021;274(4):646–53.

    PubMed  Google Scholar 

  18. Picot J, et al. Weight loss surgery for mild to moderate obesity: a systematic review and economic evaluation. Obes Surg. 2012;22(9):1496–506.

    Article  PubMed  Google Scholar 

  19. Shoar S, Saber AA. Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Relat Dis. 2017;13(2):170–80.

    Article  PubMed  Google Scholar 

  20. Ahmed B, et al. Long-term weight change and health outcomes for sleeve gastrectomy (SG) and matched Roux-en-Y gastric bypass (RYGB) participants in the longitudinal assessment of bariatric surgery (LABS) study. Surgery. 2018;164(4):774–83.

    Article  PubMed  Google Scholar 

  21. Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-en-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32.

    Article  PubMed  Google Scholar 

  22. Lager CJ, et al. Metabolic parameters, weight loss, and comorbidities 4 years after Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg. 2018;28(11):3415–23.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Howard R, et al. Comparative safety of sleeve gastrectomy and gastric bypass up to 5 years after surgery in patients with severe obesity. JAMA Surg. 2021;156(12):1160–9.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Chaar ME, Lundberg P, Stoltzfus J. Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on metabolic and bariatric surgery accreditation and quality improvement program database. Surg Obes Relat Dis. 2018;14(5):545–51.

    Article  PubMed  Google Scholar 

  25. Hu Z, et al. A comprehensive comparison of LRYGB and LSG in obese patients including the effects on QoL, comorbidities, weight loss, and complications: a systematic review and meta-analysis. Obes Surg. 2020;30(3):819–27.

    Article  PubMed  Google Scholar 

  26. Sha Y, et al. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30(5):1660–70.

    Article  PubMed  Google Scholar 

  27. Committee ACI. Bariatric surgery in class I obesity (body mass index 30–35 kg/m(2)). Surg Obes Relat Dis. 2013;9(1):e1-10.

    Article  Google Scholar 

  28. Chang SH, et al. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Doble B, et al. What are the real procedural costs of bariatric surgery? A systematic literature review of published cost analyses. Obes Surg. 2017;27(8):2179–92.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kushner BS, Eagon JC. Systematic review and meta-analysis of the effectiveness of insurance requirements for supervised weight loss prior to bariatric surgery. Obes Surg. 2021;31(12):5396–408.

    Article  PubMed  Google Scholar 

  31. Gomez-Rexrode AE, et al. Variation in pre-operative insurance requirements for bariatric surgery. Surg Endosc. 2022;36(11):8358–63.

    Article  PubMed  Google Scholar 

  32. Kim JJ, et al. ASMBS updated position statement on insurance mandated preoperative weight loss requirements. Surg Obes Relat Dis. 2016;12(5):955–9.

    Article  PubMed  Google Scholar 

  33. Funk LM, et al. Primary care physician decision making regarding severe obesity treatment and bariatric surgery: a qualitative study. Surg Obes Relat Dis. 2016;12(4):893–901.

    Article  PubMed  Google Scholar 

  34. Gebran SG, et al. Insurance coverage criteria for bariatric surgery: a survey of policies. Obes Surg. 2020;30(2):707–13.

    Article  PubMed  Google Scholar 

  35. Schauer PR, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–51.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ikramuddin S, et al. Roux-en-Y gastric bypass for diabetes (the diabetes surgery study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol. 2015;3(6):413–22.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Halpern B, Mancini MC. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI lower than 35 kg/m(2): Why caution is still needed. Obes Rev. 2019;20(5):633–47.

    Article  PubMed  Google Scholar 

  38. Wise ES, Hocking KM, Kavic SM. Prediction of excess weight loss after laparoscopic Roux-en-Y gastric bypass: data from an artificial neural network. Surg Endosc. 2016;30(2):480–8.

    Article  PubMed  Google Scholar 

  39. Yan Y, et al. Efficacy of laparoscopic gastric bypass vs laparoscopic sleeve gastrectomy in treating obesity combined with type-2 diabetes. Br J Biomed Sci. 2021;78(1):35–40.

    Article  CAS  PubMed  Google Scholar 

  40. Guh DP, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kivimaki M, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022;10(4):253–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sundbom M, et al. Substantial decrease in comorbidity 5 years after gastric bypass: a population-based study from the Scandinavian obesity surgery registry. Ann Surg. 2017;265(6):1166–71.

    Article  PubMed  Google Scholar 

  43. Westerveld D, Yang D. Through thick and thin: identifying barriers to bariatric surgery, weight loss maintenance, and tailoring obesity treatment for the future. Surg Res Pract. 2016;2016:8616581.

    PubMed  PubMed Central  Google Scholar 

  44. Nielsen HJ, et al. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. Int J Obes (Lond). 2022;46(4):739–49.

    Article  CAS  PubMed  Google Scholar 

  45. Heshmati K, et al. Comparison of early type 2 diabetes improvement after gastric bypass and sleeve gastrectomy: medication cessation at discharge predicts 1-year outcomes. Surg Obes Relat Dis. 2019;15(12):2025–32.

    Article  PubMed  Google Scholar 

  46. Horwitz D, et al. Long-term outcomes comparing metabolic surgery to no surgery in patients with type 2 diabetes and body mass index 30–35. Surg Obes Relat Dis. 2020;16(4):503–8.

    Article  PubMed  Google Scholar 

  47. Chong K, et al. National differences in remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery-subgroup analysis of 2-year results of the diabetes surgery study comparing taiwanese with americans with mild obesity (BMI 30–35 kg/m(2)). Obes Surg. 2017;27(5):1189–95.

    Article  PubMed  Google Scholar 

  48. Cummings DE, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the crossroads randomised controlled trial. Diabetologia. 2016;59(5):945–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Ikramuddin S, et al. Durability of addition of Roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: a randomized control trial. Diabetes Care. 2016;39(9):1510–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Ding SA, et al. Adjustable gastric band surgery or medical management in patients with type 2 diabetes: a randomized clinical trial. J Clin Endocrinol Metab. 2015;100(7):2546–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Courcoulas AP, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015;150(10):931–40.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Halperin F, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149(7):716–26.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Wentworth JM, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial. Lancet Diabetes Endocrinol. 2014;2(7):545–52.

    Article  PubMed  Google Scholar 

  54. Parikh M, et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg. 2014;260(4):617–22 (discussion 622–4).

    Article  PubMed  Google Scholar 

  55. Liang Z, et al. Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract. 2013;101(1):50–6.

    Article  PubMed  Google Scholar 

  56. O’Brien PE, et al. Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial. Obes Surg. 2013;23(9):1345–53.

    Article  PubMed  Google Scholar 

  57. Dixon JB, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23.

    Article  CAS  PubMed  Google Scholar 

  58. Stenberg E, et al. Comparison of sleeve gastrectomy vs intensive lifestyle modification in patients with a BMI of 30 to less than 35. JAMA Netw Open. 2022;5(7):e2223927.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Studer AS, et al. Five-year outcomes after surgery for class 1 obesity: a retrospective analysis of a Canadian bariatric centre’s experience. Can J Surg. 2022;65(6):E763–9.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Sen O, et al. Sleeve gastrectomy in class 1 obesity: Aassessment of operative outcomes. Surg Obes Relat Dis. 2021;17(1):170–6.

    Article  PubMed  Google Scholar 

  61. Singh D, et al. Five-year outcomes of sleeve gastrectomy in patients with class i obesity and type 2 diabetes mellitus. Obes Surg. 2022;32(1):96–102.

    Article  PubMed  Google Scholar 

  62. Baldwin D, et al. Metabolic surgery outcomes in U.S. patients with class I obesity. Bariatr Surg Pract Patient Care. 2021;16(2):85–91.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Wu D, Wang L, Jiang T. Efficacy comparison of laparoscopic sleeve gastrectomy in type 2 diabetes patients with a BMI 30–349 kg/m (2) versus BMI< 30 kg/m(2). Surg Endosc. 2021;35(4):1544–50.

    Article  PubMed  Google Scholar 

  64. Vitiello A, et al. Bariatric surgery versus lifestyle intervention in class I obesity: 7–10-year results of a retrospective study. World J Surg. 2019;43(3):758–62.

    Article  PubMed  Google Scholar 

  65. Berry MA, et al. Sleeve gastrectomy outcomes in patients with BMI between 30 and 35–3 years of follow-up. Obes Surg. 2018;28(3):649–55.

    Article  PubMed  Google Scholar 

  66. Kular KS, Manchanda N, Cheema GK. Seven years of mini-gastric bypass in type II diabetes patients with a body mass index <35 kg/m(2). Obes Surg. 2016;26(7):1457–62.

    Article  PubMed  Google Scholar 

  67. Noun R, et al. Results of laparoscopic sleeve gastrectomy in 541 consecutive patients with low baseline body mass index (30–35 kg/m(2)). Obes Surg. 2016;26(12):2824–8.

    Article  PubMed  Google Scholar 

  68. Cohen RV, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Parikh M, Duncombe J, Fielding GA. Laparoscopic adjustable gastric banding for patients with body mass index of <or=35 kg/m2. Surg Obes Relat Dis. 2006;2(5):518–22.

    Article  CAS  PubMed  Google Scholar 

  70. Kashyap SR, et al. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the surgical therapy and medications potentially eradicate diabetes efficiently trial (STAMPEDE). Diabetes Obes Metab. 2010;12(5):452–4.

    Article  PubMed  Google Scholar 

  71. O’Brien PE, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33.

    Article  PubMed  Google Scholar 

  72. Lee WJ, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.

    Article  PubMed  Google Scholar 

  73. Sierzantowicz R, Ladny JR, Lewko J. Quality of life after bariatric surgery-a systematic review. Int J Environ Res Public Health. 2022;19(15):9078.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Li Y, et al. Is bariatric surgery effective for chinese patients with type 2 diabetes mellitus and body mass index < 35 kg/m(2)? A systematic review and meta-analysis. Obes Surg. 2021;31(9):4083–92.

    Article  PubMed  Google Scholar 

  75. Parmar CD, Zakeri R, Mahawar K. A systematic review of one anastomosis/mini gastric bypass as a metabolic operation for patients with body mass index </= 35 kg/m(2). Obes Surg. 2020;30(2):725–35.

    Article  PubMed  Google Scholar 

  76. Feng X, et al. How safe is bariatric surgery in patients with class I obesity (body mass index 30–35 kg/m(2))? Surg Obes Relat Dis. 2019;15(2):253–60.

    Article  PubMed  Google Scholar 

  77. Murtha JA, et al. Perioperative cost differences between laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass: a single institutional review. J Laparoendosc Adv Surg Tech A. 2021;31(9):993–8.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Jordan K, et al. Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations. Eur J Health Econ. 2022. https://doi.org/10.1007/s10198-022-01494-2.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness–the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371(9):796–7.

    Article  CAS  PubMed  Google Scholar 

  80. Glass J, et al. New era: endoscopic treatment options in obesity-a paradigm shift. World J Gastroenterol. 2019;25(32):4567–79.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Ard J, et al. Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists. Adv Ther. 2021;38(6):2821–39.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Gao X, et al. Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. 2022;13:935823.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Sarma S, Palcu P. Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: a systematic review and meta-analysis. Obesity. 2022;30(11):2111–21.

    Article  PubMed  Google Scholar 

  84. • Frias JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503–15. This is a critical study underscoring the emerging power of anti-obesity medications, which will ostensibly influence candidacy for surgery in patient with Class 1 obesity.

  85. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–16.

    Article  CAS  PubMed  Google Scholar 

  86. Khera R, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Fidler MC, et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the blossom trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.

    Article  CAS  PubMed  Google Scholar 

  88. Greenway FL, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595–605.

    Article  CAS  PubMed  Google Scholar 

  89. Allison DB, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20(2):330–42.

    Article  CAS  PubMed  Google Scholar 

  90. Behary J, Kumbhari V. Advances in the endoscopic management of obesity. Gastroenterol Res Pract. 2015;2015:757821.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Genco A, et al. Bioenterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15(8):1161–4.

    Article  CAS  PubMed  Google Scholar 

  92. Gaur S, et al. Balancing risk and reward: a critical review of the intragastric balloon for weight loss. Gastrointest Endosc. 2015;81(6):1330–6.

    Article  PubMed  Google Scholar 

  93. Chan DL, et al. Outcomes with intra-gastric balloon therapy in BMI < 35 non-morbid obesity: 10-year follow-up study of an RCT. Obes Surg. 2021;31(2):781–6.

    Article  PubMed  Google Scholar 

  94. Abu Dayyeh BK, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017;15(1):37-43 e1.

    Article  PubMed  Google Scholar 

  95. Abu Dayyeh BK, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022;400(10350):441–51.

    Article  PubMed  Google Scholar 

  96. Cheng Q, et al. Reversal of endoscopic sleeve gastroplasty and conversion to sleeve gastrectomy—two case reports. Int J Surg Case Rep. 2020;68:180–4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

  1. University of Minnesota Medical School, Minneapolis, MN, USA

    Adam W. Scott

  2. Department of Surgery, University of Minnesota Medical School, Minneapolis, MN, USA

    Daniel B. Leslie, Sayeed Ikramuddin & Eric S. Wise

  3. Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA

    Nirjhar Dutta & Stuart K. Amateau

  4. Department of Surgery, Division of Advanced GI/Bariatric Surgery, University of Minnesota Medical School, 420 Delaware St SE MMC 195, Minneapolis, MN, 55455, USA

    Eric S. Wise

Authors
  1. Adam W. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel B. Leslie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sayeed Ikramuddin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nirjhar Dutta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stuart K. Amateau
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Eric S. Wise
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AS and EW wrote the main manuscript text; DL, ND, SA, and SI assisted with manuscript outline and editing; AS and EW assisted in Table preparation, All authors thoroughly reviewed and gave final approval of the manuscript.

Corresponding author

Correspondence to Eric S. Wise.

Ethics declarations

Conflict of interest

None of the authors have any competing interests.

Ethical Approval

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scott, A.W., Leslie, D.B., Ikramuddin, S. et al. The Case for Bariatric Surgery in Patients with Class 1 Obesity. Curr Surg Rep 11, 127–136 (2023). https://doi.org/10.1007/s40137-023-00355-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40137-023-00355-y

Keywords

Search

Navigation